Effort Underway To Make Generic Biotech Drugs Available Sooner

By: Associated Press Email
By: Associated Press Email

Stay up-to-date with KAKE News:

Thursday, March 26, 2009

The most expensive drugs now on the market could have to compete with lower-cost generic versions just five years after launching, under a new congressional proposal.

A bipartisan bill introduced in the Senate aims to reduce the cost of biotech drugs, high-tech injectable medicines that can cost thousands of dollars per month.

Efforts to create a pathway for generic biotech drugs have been bogged down for years by disagreements between biotech and generic drugmakers.

But with President Obama and other Democrats pushing the issue as a cost saver, the generic drug industry is poised to realize its long-sought goal: a speedy path to market for lower-cost biotech.

Comments are posted from viewers like you and do not always reflect the views of this station.
powered by Disqus
KAKE TV 1500 N. West Street Wichita, KS 67203-1323 (316) 943-4221
Copyright © 2002-2014 - Designed by Gray Digital Media - Powered by Clickability 41925472 - kake.com/a?a=41925472
Gray Television, Inc.